CSIMarket Company Name, Ticker, Customers, else..
 
Simulations Plus Inc   (NASDAQ: SLP)
 
Price: $18.4300 $0.01 0.054%
Day's High: $18.450000762939453 Week Perf: 0.05 %
Day's Low: $ 18.41 30 Day Perf: 0.44 %
Volume (M): 257,085 52 Wk High: $ 21.01
Volume (M$): $ 0 52 Wk Avg: $16.26
Open: $18.42 52 Wk Low: $11.09



 Market Capitalization (Millions $) 373
 Shares Outstanding (Millions) 20
 Employees 213
 Revenues (TTM) (Millions $) 81
 Net Income (TTM) (Millions $) 8
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 3

Business Description


Simulations Plus Inc is a leading provider of simulation and modeling software for the pharmaceutical and biotechnology industries. The company develops and sells a range of software solutions that aid in the prediction and analysis of drug efficacy and safety. Their software helps researchers and scientists streamline the drug discovery and development process, ultimately saving time and resources. Simulations Plus Inc is renowned for their expertise in pharmacokinetic and physiologically-based pharmacokinetic modeling, and their products are used by pharmaceutical companies, regulatory agencies, and academic institutions worldwide.


   Company Address: 800 Park Offices Drive, Suite 401 Research Triangle Park 27709 NC
   Company Phone Number: 723-7723   Stock Exchange / Ticker: NASDAQ SLP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CERT        0.73% 
• View Complete Report
   



Announcement

Simulations Plus, Inc. Under Scrutiny Legal Experts Investigate Potential Misleading Information Impacting Investors

Published Wed, Sep 24 2025 12:51 AM UTC

Simulations Plus, Inc. Faces Legal Examination Amid Investor Concerns On September 23, 2025, The Rosen Law Firm, a globally recognized leader in securities litigation, issued a noteworthy announcement that has caught the attention of investors worldwide. The firm, renowned for protecting the rights of shareholders, revealed an ongoing investigation into potential securities ...
Announcement

Legal Scrutiny Intensifies Investigations into Simulations Plus Inc. Over Potential Securities Misrepresentation

Published Mon, Sep 22 2025 4:40 AM UTC

Simulations Plus, Inc. (NASDAQ: SLP), a notable player in the pharmaceutical software simulation industry, finds itself under heightened scrutiny as two prominent law firms, Rosen Law Firm and Pomerantz LLP, have launched separate investigations into the company s financial representations. The investigations are driven by allegations that Simulations Plus may have potential...
Announcement

Investor Alarm Simulations Plus Faces Scrutiny Amid Stock Plunge and Auditor Turmoil,

Published Thu, Aug 28 2025 11:37 AM UTC

| CSIMarket.com | Simulations Plus, Inc. (NASDAQ: SLP) is under intense scrutiny following a dramatic downturn in its stock price and unsettling disclosures that have prompted an investigation by the renowned law firm Hagens Berman. On July 15, 2025, shares of the digital simulation and modeling company plummeted nearly 25%, raising alarms among investors and market anal...
Announcement

Pomerantz Law Firm Investigates Simulations Plus, Inc. for Potential Investor Misrepresentation - Immediate Action Ad...

Published Wed, Jul 23 2025 3:10 PM UTC

Pomerantz Law Firm Launches Investigation into Simulations Plus, Inc. - What Investors Should Know On July 23, 2025, the Pomerantz Law Firm, a recognized leader in the field of class action lawsuits, announced the initiation of an investigation concerning the business practices and claims surrounding Simulations Plus, Inc., a publicly traded company under NASDAQ: SLP. This i...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 46.52
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.58
Price to Sales (Expected) -
Price to Book 2.68
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.69
Working Capital Ratio 5.55
Leverage Ratio (MRQ) 0.1
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.4 $
Revenues (TTM) 4.02 $
Cash Flow (TTM) -
Cash 2.47 $
Book Value 6.87 $
Dividend (TTM) 0.06 $

Efficiency Current
Revenue per Employee (TTM) 382,094
Net Income per Employee (TTM) 38,052
Receivable Turnover Ratio (TTM) 5.94
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.58

Profitability Ratios Current
Gross Margin (MRQ) 69.13 %
Operating Margin (MRQ) 20.55 %
Net Margin (MRQ) 16.33 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 35.42 %

Management Effectiveness Current
Return On Assets (TTM) 5.76 %
Return On Investment (TTM) 6.19 %
Return On Equity (TTM) 6.21 %
Dividend Yield 0.33 %
Pay out Ratio (TTM) 30.29 %



Simulations Plus Inc's Segments
License and Maintenance    165.02 % of total Revenue
Service    130.06 % of total Revenue
Asia Pacific    9.21 % of total Revenue
Software    165.02 % of total Revenue
Services    130.06 % of total Revenue
Americas    210.51 % of total Revenue
EMEA    26.68 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.